Back
Sirius XM Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
38
SIRI
Sirius XM Holdings
Last Price:
$22.74
Seasonality Move:
10.19%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
38
Sirius XM Holdings (SIRI)
is a Sell
Is Sirius XM Holdings a Buy, Sell or Hold?
-
The current Sirius XM Holdings [SIRI] share price is $23.82. The Score for SIRI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SIRI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SIRI Stock Price Chart
What is Sirius XM Holdings's stock price today?
-
The Sirius XM Holdings share price today is $23.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SIRI is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
SIRI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 50.88 | Buy |
| Chaikin Money Flow: | 870296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.84 - 24.56) | Buy |
| Bollinger Bands (100): | (22.42 - 26.36) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.53 | Buy |
| Relative Strength Index (14 RSI): | 57.28 | Buy |
| Chaikin Money Flow: | 106003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.42 - 267) | Buy |
| Bollinger Bands (100): | (240.58 - 270.64) | Buy |
SIRI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.52 | Buy |
| 20-day SMA: | 23.45 | Buy |
| 50-day SMA: | 23.79 | Buy |
| 200-day SMA: | 26.83 | Sell |
| 8-day EMA: | 23.65 | Buy |
| 20-day EMA: | 23.65 | Buy |
| 50-day EMA: | 23.89 | Sell |
| 200-day EMA: | 27.44 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 268.31 | Buy |
| 20-day SMA: | 253.84 | Buy |
| 50-day SMA: | 259.68 | Buy |
| 200-day SMA: | 253.36 | Buy |
| 8-day EMA: | 268.69 | Buy |
| 20-day EMA: | 260.57 | Buy |
| 50-day EMA: | 257.45 | Buy |
| 200-day EMA: | 244.33 | Buy |
Sirius XM Holdings Earnings Growth & SIRI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.19 per share, an increase this year of $9.16 per share, and an increase next year of $0.03 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Sirius XM Holdings Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||